Blockchain Registration Transaction Record
Tonix Pharmaceuticals Reports Q3 2024 Financial Results and Advances Drug Pipeline
Tonix Pharmaceuticals reports Q3 2024 financial results and highlights drug pipeline advancements for fibromyalgia, mpox vaccines, and cocaine intoxication. FDA Fast Track designation underscores commitment to CNS disorders and infectious disease treatments.
This news matters as it highlights the progress and commitment of Tonix Pharmaceuticals in developing innovative treatments for fibromyalgia, mpox vaccines, and cocaine intoxication. The Fast Track designation from the FDA for TNX-102 SL showcases the potential impact of these treatments on patients with central nervous system disorders and infectious diseases.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xf236c8056703d2ef1dec9c1eb10718e3ad26651130fad011b177b107060d6986 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | iconn7yB-29dec1b320ada202c7407fd195769065 |